Bioprocessing & Bioproduction In-Depth Focus 2019
Posted: 25 June 2019 | European Pharmaceutical Review | No comments yet
The process of manufacturing a biotherapeutic drug entails numerous quality control measures to ensure safety and efficacy. The articles in this in-depth focus discuss higher order structure analysis and host cell protein contamination issues.
- A contribution from scientists at Celldex Therapeutics describes how they ensure higher order structure (HOS) is maintained by monitoring it throughout the production process.
- This article by Vanda Dolabela de Magalhães highlights a concern in biotechnological product manufacture; that of host cell protein contamination. You can hear the thoughts of six Brazilian companies that work in the field regarding how remaining low-level contamination should be tackled.
